Major win: Bhattacharya on NIH hypertension clinical trial

Intervention costing about $760 per patient shows potential to cut cardiovascular events and ease provider burden.

Malvika Choudhary•Apr 18, 2026 07:55 AM• 147 views

U.S. National Institutes of Health (NIH) Director Jay Bhattacharya testifies before a Senate Appropriations Committee hearing on U.S. President Donald Trump's budget request for the NIH, on Capitol Hill in Washington, D.C., U.S., June 10, 2025.

Credit: REUTERS/Kent Nishimura

Share this Article:

Malvika Choudhary

Author

View Profile